Trade Summary

6 days ago, Azamian Bobak R., serving as Pres, CEO, Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 34,603 shares at $68.34 per share, for a total transaction value of $2,364,904.00. Following this transaction, Azamian Bobak R. now holds 891,412 shares of TARS.

This sale represents a 4.00% decrease in Azamian Bobak R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.